ArticleUrologie (Heidelberg, Germany)2026

[Added benefits of systemic uro-oncological therapies-risk of recourse following elimination of the special practice designation : Part 1: prostate cancer].

Manfred Johannsen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.